Serum androgen dynamics in young women aged 18-40 treated with chemotherapy for breast cancer: an observational, multicentric, prospective study in France

References

• Abraham, G. E. (1974). Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. The Journal of Clinical Endocrinology and Metabolism, 39(2), 340–346. https://doi.org/10.1210/jcem-39-2-340
   PubMed Web of Science ®Google Scholar
• Anderson, R. A., Brewster, D. H., Wood, R., Nowell, S., Fischbacher, C., Kelsey, T. W., & Wallace, W. H. B. (2018). The impact of cancer on subsequent chance of pregnancy: a population-based analysis. Human Reproduction (Oxford, England), 33(7), 1281–1290. https://doi.org/10.1093/humrep/dey216
   PubMed Web of Science ®Google Scholar
• Blumenfeld, Z. (2012). Chemotherapy and fertility. Best Practice & Research. Clinical Obstetrics & Gynaecology, 26(3), 379–390. https://doi.org/10.1016/j.bpobgyn.2011.11.008
   PubMed Web of Science ®Google Scholar
• Burger, H. G. (2002). Androgen production in women. Fertility and Sterility, 77 (Suppl 4), S3–S5. https://doi.org/10.1016/s0015-0282(02)02985-0
   PubMed Web of Science ®Google Scholar
• Cameron, K., Sammel, M. D., Prewitt, M. M., Lynch, M. E., & Gracia, C. (2016). Impact of chemotherapy on androgen and follicular measures of ovarian reserve in female cancer survivors. Fertility and Sterility, 106(3), e128. https://doi.org/10.1016/j.fertnstert.2016.07.383
   Web of Science ®Google Scholar
• Chung, M., Chang, H. R., Bland, K. I., & Wanebo, H. J. (1996). Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 77(1), 97–103. https://doi.org/10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Cronin, K. A., Lake, A. J., Scott, S., Sherman, R. L., Noone, A.-M., Howlader, N., Henley, S. J., Anderson, R. N., Firth, A. U., Ma, J., Kohler, B. A., & Jemal, A. (2018). Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer, 124(13), 2785–2800. https://doi.org/10.1002/cncr.31551
   PubMed Web of Science ®Google Scholar
• Davison, S. L., & Davis, S. R. (2003). Androgens in women. The Journal of Steroid Biochemistry and Molecular Biology, 85(2-5), 363–366. https://doi.org/10.1016/s0960-0760(03)00204-8
   PubMed Web of Science ®Google Scholar
• Davison, S. L., Bell, R., Donath, S., Montalto, J. G., & Davis, S. R. (2005). Androgen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy. The Journal of Clinical Endocrinology and Metabolism, 90(7), 3847–3853. https://doi.org/10.1210/jc.2005-0212
   PubMed Web of Science ®Google Scholar
• Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., Mason, H., Nelson, S. M., Visser, J. A., Wallace, W. H., & Anderson, R. A. (2014). The physiology and clinical utility of anti-Mullerian hormone in women. Human Reproduction Update, 20(3), 370–385. https://doi.org/10.1093/humupd/dmt062
   PubMed Web of Science ®Google Scholar
• Dezellus, A., Barriere, P., Campone, M., Lemanski, C., Vanlemmens, L., Mignot, L., Delozier, T., Levy, C., Bendavid, C., Debled, M., Bachelot, T., Jouannaud, C., Loustalot, C., Mouret-Reynier, M. A., Gallais-Umbert, A., Masson, D., & Freour, T. (2017). Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer. European Journal of Cancer (Oxford, England: 1990), 79, 72–80. https://doi.org/10.1016/j.ejca.2017.03.035
   PubMed Web of Science ®Google Scholar
• Dnistrian, A. M., Greenberg, E. J., Dillon, H. J., Hakes, T. B., Fracchia, A. A., & Schwartz, M. K. (1985). Chemohormonal therapy and endocrine function in breast cancer patients. Cancer, 56(1), 63–70. https://doi.org/10.1002/1097-0142(19850701)56:1<63::aid-cncr2820560111>3.0.co;2-7
   PubMed Web of Science ®Google Scholar
• Dowsett, M., & Richner, J. (1991). Effects of cytotoxic chemotherapy on ovarian and adrenal steroidogenesis in pre-menopausal breast cancer patients. Oncology, 48(3), 215–220. https://doi.org/10.1159/000226930
   PubMed Web of Science ®Google Scholar
• Drakopoulos, P., Bardhi, E., Scherer, S., Blockeel, C., Verheyen, G., Anckaert, E., Tournaye, H., & Polyzos, N. P. (2021). Androgens and Anti-Müllerian Hormone in Infertile Patients. Reproductive Sciences (Thousand Oaks, Calif.), 28(10), 2816–2821. https://doi.org/10.1007/s43032-021-00539-w
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England), 365(9472), 1687–1717. https://doi.org/10.1016/S0140-6736(05)66544-0
   PubMed Web of Science ®Google Scholar
• Eifel, P., Axelson, J. A., Costa, J., Crowley, J., Curran, W. J., Deshler, A., Fulton, S., Hendricks, C. B., Kemeny, M., Kornblith, A. B., Louis, T. A., Markman, M., Mayer, R., & Roter, D. (2001). National institutes of health consensus development conference statement: Adjuvant therapy for breast cancer, November 1-3, 2000. Journal of the National Cancer Institute, 93(13), 979–989. https://doi.org/10.1093/jnci/93.13.979
   PubMed Web of Science ®Google Scholar
• Fidler, M. M., Gupta, S., Soerjomataram, I., Ferlay, J., Steliarova-Foucher, E., & Bray, F. (2017). Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. The Lancet. Oncology, 18(12), 1579–1589. https://doi.org/10.1016/S1470-2045(17)30677-0
   PubMed Web of Science ®Google Scholar
• Ghoncheh, M., Pournamdar, Z., & Salehiniya, H. (2016). Incidence and mortality and epidemiology of breast cancer in the world. Asian Pacific Journal of Cancer Prevention: APJCP, 17(S3), 43–46. https://doi.org/10.7314/apjcp.2016.17.s3.43
   PubMedGoogle Scholar
• Goldhirsch, A., Glick, J. H., Gelber, R. D., & Senn, H. J. (1998). Meeting highlights: International consensus panel on the treatment of primary breast cancer. Journal of the National Cancer Institute, 90(21), 1601–1608. https://doi.org/10.1093/jnci/90.21.1601
   PubMedGoogle Scholar
• Jamil, Z., Fatima, S. S., Ahmed, K., & Malik, R. (2016). Anti-mullerian hormone: Above and beyond conventional ovarian reserve markers. Disease Markers, 2016, 5246217–5246219. https://doi.org/10.1155/2016/5246217
   PubMed Web of Science ®Google Scholar
• Kim, H.-A., Choi, J., Park, C. S., Seong, M.-K., Hong, S.-E., Kim, J.-S., Park, I.-C., Lee, J. K., & Noh, W. C. (2018). Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery. Endocrine Connections, 7(8), 949–956. https://doi.org/10.1530/EC-18-0180
   PubMed Web of Science ®Google Scholar
• Lambertini, M., Goldrat, O., Toss, A., Azim, H. A., Peccatori, F. A., Ignatiadis, M., Del Mastro, L., & Demeestere, I. (2017). Fertility and pregnancy issues in BRCA-mutated breast cancer patients. Cancer Treatment Reviews, 59, 61–70. https://doi.org/10.1016/j.ctrv.2017.07.001
   PubMed Web of Science ®Google Scholar
• Lambertini, M., Olympios, N., Lequesne, J., Calbrix, C., Fontanilles, M., Loeb, A., Leheurteur, M., Demeestere, I., Di Fiore, F., Perdrix, A., & Clatot, F. (2019). Impact of taxanes, endocrine therapy, and deleterious germline BRCA mutations on anti-müllerian hormone levels in early breast cancer patients treated with anthracycline- and cyclophosphamide-based chemotherapy. Frontiers in Oncology, 9, 575. https://doi.org/10.3389/fonc.2019.00575
   PubMed Web of Science ®Google Scholar
• Lebbe, M., & Woodruff, T. K. (2013). Involvement of androgens in ovarian health and disease. Molecular Human Reproduction, 19(12), 828–837. https://doi.org/10.1093/molehr/gat065
   PubMed Web of Science ®Google Scholar
• Lucis, O. J., Hobkirk, R., Hollenberg, C. H., MacDonald, S. A., & Blahey, P. (1966). Polycystic ovaries associated with congenital adrenal hyperplasia. Canadian Medical Association Journal, 94(1), 1–7.
   PubMed Web of Science ®Google Scholar
• Mastro, L. D., Catzeddu, T., & Venturini, M. (2006). Infertility and pregnancy after breast cancer: Current knowledge and future perspectives. Cancer Treatment Reviews, 32(6), 417–422. https://doi.org/10.1016/j.ctrv.2006.05.004
   PubMed Web of Science ®Google Scholar
• Morgan, S., Anderson, R. A., Gourley, C., Wallace, W. H., & Spears, N. (2012). How do chemotherapeutic agents damage the ovary? Human Reproduction Update, 18(5), 525–535. https://doi.org/10.1093/humupd/dms022
   PubMed Web of Science ®Google Scholar
• Pache, T. D., & Fauser, B. C. (1993). Polycystic ovaries in female-to-male transsexuals. Clinical Endocrinology, 39(6), 702–703.
   PubMed Web of Science ®Google Scholar
• Partridge, A. H., & Ruddy, K. J. (2007). Fertility and adjuvant treatment in young women with breast cancer. Breast (Edinburgh, Scotland), 16 Suppl 2, S175–S181. https://doi.org/10.1016/j.breast.2007.07.029
   PubMedGoogle Scholar
• Rose, D. P., & Davis, T. E. (1980). Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Cancer Research, 40(11), 4043–4047.
   PubMed Web of Science ®Google Scholar
• Rosendahl, M., Andersen, C. Y., la Cour Freiesleben, N., Juul, A., Løssl, K., & Andersen, A. N. (2010). Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertility and Sterility, 94(1), 156–166. https://doi.org/10.1016/j.fertnstert.2009.02.043
   PubMed Web of Science ®Google Scholar
• Sklar, C. A., Mertens, A. C., Mitby, P., Whitton, J., Stovall, M., Kasper, C., Mulder, J., Green, D., Nicholson, H. S., Yasui, Y., & Robison, L. L. (2006). Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. Journal of the National Cancer Institute, 98(13), 890–896. https://doi.org/10.1093/jnci/djj243
   PubMed Web of Science ®Google Scholar
• Spears, N., Lopes, F., Stefansdottir, A., Rossi, V., De Felici, M., Anderson, R. A., & Klinger, F. G. (2019). Ovarian damage from chemotherapy and current approaches to its protection. Human Reproduction Update, 25(6), 673–693. https://doi.org/10.1093/humupd/dmz027
   PubMed Web of Science ®Google Scholar
• Walters, K. A. (2015). Role of androgens in normal and pathological ovarian function. Reproduction, 149(4), R193–R218. https://doi.org/10.1530/REP-14-0517
   PubMed Web of Science ®Google Scholar
• Walters, K. A., Rodriguez Paris, V., Aflatounian, A., & Handelsman, D. J. (2019). Androgens and ovarian function: translation from basic discovery research to clinical impact. The Journal of Endocrinology, 242(2), R23–R50. https://doi.org/10.1530/JOE-19-0096
   PubMed Web of Science ®Google Scholar